Park Ha Biological Technology is trading at $2.83 (+12.07%) in pre-market, with no confirmed company-specific catalyst identified.
- The company’s release page lists no announcement dated October 9–12.
- The October 2 offering mention is prior context, not an established trigger.
- Major U.S. indices were mixed, with none moving more than 0.5%, so broad-market direction does not clearly explain the gain. Premarket volume and trading activity level remain unconfirmed.